Impact of early initiation of sodium-glucose cotransporter 2 inhibitor on cardiovascular outcomes in people with diabetes and known or at risk of atherosclerotic cardiovascular disease: Propensity score matched analysis

OBJECTIVE: We aimed to evaluate the impact of early initiation of sodium-glucose cotransporter 2 inhibitors (SGLT2i) on cardiovascular (CV) outcomes in people with type 2 diabetes (T2D) with known or at risk of atherosclerotic cardiovascular disease (ASCVD). RESEARCH DESIGN AND METHODS: T2D with fir...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Wen, Kong, Alice P. S., Yan, Bryan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635734/
https://www.ncbi.nlm.nih.gov/pubmed/36331955
http://dx.doi.org/10.1371/journal.pone.0277321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635734/
https://www.ncbi.nlm.nih.gov/pubmed/36331955
http://dx.doi.org/10.1371/journal.pone.0277321

Ejemplares similares